KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent Deferred RevenueDividends payablesLand & ImprovementsLiabilities and Shareholders EquityLoans - NetMinority InterestOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Payables (2016 - 2025)

Historic Payables for National Health Investors (NHI) over the last 17 years, with Q3 2025 value amounting to $78.5 million.

  • National Health Investors' Payables rose 935.38% to $78.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.5 million, marking a year-over-year increase of 935.38%. This contributed to the annual value of $78.9 million for FY2024, which is 750.0% up from last year.
  • Per National Health Investors' latest filing, its Payables stood at $78.5 million for Q3 2025, which was up 935.38% from $75.8 million recorded in Q2 2025.
  • In the past 5 years, National Health Investors' Payables registered a high of $78.9 million during Q4 2024, and its lowest value of $60.4 million during Q1 2022.
  • Its 5-year average for Payables is $68.9 million, with a median of $68.0 million in 2023.
  • In the last 5 years, National Health Investors' Payables plummeted by 2370.06% in 2021 and then skyrocketed by 1295.97% in 2023.
  • National Health Investors' Payables (Quarter) stood at $64.4 million in 2021, then grew by 0.79% to $65.0 million in 2022, then increased by 12.96% to $73.4 million in 2023, then increased by 7.5% to $78.9 million in 2024, then fell by 0.5% to $78.5 million in 2025.
  • Its Payables stands at $78.5 million for Q3 2025, versus $75.8 million for Q2 2025 and $71.2 million for Q1 2025.